Equities

Koa Shoji Holdings Co Ltd

9273:TYO

Koa Shoji Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)839.00
  • Today's Change13.00 / 1.57%
  • Shares traded78.10k
  • 1 Year change+17.84%
  • Beta0.7239
Data delayed at least 20 minutes, as of Apr 26 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

KOA SHOJI HOLDINGS CO., LTD. is engaged in purchasing and sales of drug substance, manufacturing, purchasing and sales of pharmaceuticals, including medical prescription drugs and general pharmaceutical products, as well as contract manufacturing of formulation of pharmaceuticals. The Company operates through two business segments. The pharmaceutical manufacturing and sales business is engaged in development, manufacturing, contract manufacturing and sales of generic injection, oral preparation and external preparation. The drug substance sales business is engaged in import and export of generic drug raw materials, as well as introducing and supply of pharmaceutical raw materials and preparations.

  • Revenue in JPY (TTM)22.27bn
  • Net income in JPY2.86bn
  • Incorporated2015
  • Employees297.00
  • Location
    Koa Shoji Holdings Co Ltd7-13-15, Hiyoshi, Kohoku-kuYOKOHAMA-SHI 223-0061JapanJPN
  • Phone+81 455606607
  • Websitehttps://www.koashoji-hd.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
TAIKO PHARMACEUTICAL CO LTD6.12bn-3.61bn17.22bn208.00--2.52--2.81-73.48-73.48129.22134.920.4332.133.2429,423,080.00-25.54---32.19--42.11---58.99--2.54--0.3256--21.43--26.23------
Astena Holdings Co Ltd52.63bn1.62bn19.88bn1.40k11.840.67135.170.377740.9840.981,332.61722.460.81273.312.7637,482,540.002.492.494.444.4432.2725.333.062.320.8713--0.351744.924.73-2.85100.61-3.8538.5411.38
Fuso Pharmaceutical Industries Ltd54.63bn1.34bn20.92bn1.31k14.290.51935.940.3831154.89154.896,295.264,263.410.7253.312.2041,572,300.001.781.792.952.8725.2927.782.452.591.0965.130.283545.952.792.148.2310.60-1.72-2.64
Medical Data Vision Co Ltd6.42bn979.13m23.58bn262.0022.985.2922.323.6725.6325.63168.05111.301.15140.016.1124,500,100.0017.1716.1624.0120.8878.3881.9014.8715.522.5824.660.0019.985.1512.4012.4869.75-23.95--
Pharma Foods International Co., Ltd.65.08bn4.76bn24.11bn670.005.022.534.490.3704165.17165.172,257.80327.801.842.2212.7197,135,820.0013.448.4048.1219.2079.8981.347.323.850.844991.330.683928.2613.9453.90923.8057.9251.63--
Cuorips Inc39.89m-598.68m26.14bn46.00--4.32--655.40-76.49-76.495.13766.300.00813.9339.73867,130.40-12.10---12.39--45.79---1,500.91--35.89--0.00--175.12---20.45------
StemRIM Inc2.35bn179.40m26.74bn44.00127.072.72--11.38-0.1097-0.109737.43159.710.2453----53,409,090.001.87-6.711.89-6.83----7.63-45.8078.90652.720.00--10,128.0663.68108.64------
SanBio Co Ltd0.00-2.64bn28.34bn29.00--10.05-----40.50-40.500.0041.110.00----0.00-43.74-42.00-52.38-48.88-------4,790.72----0.1923------52.44--53.94--
Mizuho Medy Co Ltd10.99bn3.77bn31.62bn180.008.382.027.972.88396.27396.271,153.851,645.860.57762.042.0461,054,080.0019.8431.4623.7039.7873.4774.8534.3433.646.45--0.0034.83-37.4911.34-51.8532.64-17.7432.85
Koa Shoji Holdings Co Ltd22.27bn2.86bn32.73bn297.0011.461.499.191.4772.0972.09562.08554.930.77775.992.4274,979,020.009.977.9112.389.9330.1228.7412.8310.483.6929.240.119719.648.358.2713.9029.60-21.2615.52
Fuji Pharma Co Ltd41.64bn5.06bn38.20bn1.62k7.410.89364.650.9173208.19208.191,713.271,726.700.50391.402.8225,687,230.006.124.108.905.5838.5142.4112.157.550.7165--0.394731.1715.421.5227.410.370919.045.73
Daito Pharmaceutical Co Ltd45.19bn3.28bn39.09bn1.01k11.980.75195.750.8649207.85207.852,864.813,311.810.61931.812.6544,701,280.004.356.995.649.2921.3822.717.038.831.15--0.123117.083.772.49-22.883.437.4812.70
Seikagaku Corp34.68bn1.31bn41.76bn976.0030.620.559214.431.2024.0024.00635.691,314.470.44311.754.3135,530,740.001.670.4381.800.479750.5255.913.771.075.44--0.0055452.20-4.002.09-40.10-10.638.400.00
Data as of Apr 26 2024. Currency figures normalised to Koa Shoji Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

4.99%Per cent of shares held by top holders
HolderShares% Held
SBI Asset Management Co., Ltd.as of 22 Jul 2022839.70k2.12%
Nomura Asset Management Co., Ltd.as of 29 Mar 2024481.50k1.22%
Nikko Asset Management Co., Ltd.as of 05 Apr 2024210.90k0.53%
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024205.60k0.52%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 202482.80k0.21%
Dimensional Fund Advisors LPas of 04 Apr 202457.60k0.15%
BlackRock Japan Co. Ltd.as of 04 Apr 202438.20k0.10%
Acadian Asset Management LLCas of 31 Jan 202423.70k0.06%
Mandarine Gestion SAas of 30 Jun 202319.60k0.05%
Asset Management One Co., Ltd.as of 04 Apr 202419.20k0.05%
More ▼
Data from 22 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.